 | | Emtricitabine (Emtriva) |  | | Published
July 07, 2003; Updated
February 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-01-08 | | | Selected References | | 3. | Wakeford C, Shen G, Hulett L, et al. Long-term efficacy and safety of emtricitabine in HIV+ adults switching from a lamivudine containing HAART regimen. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2003; Boston. Abstract 550. | |
| 4. | Campo R, Dejesus E, Bredeek UF, et al. SWIFT: Prospective 48 week study to evaluate efficacy and safety of switching to emtricitibine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen. Clin Infect Dis. 2013 Jan 29. | |
|
|
|
